SynthesisDiabetes & vascular disease research

Cardiovascular and renal outcomes of GLP-1 receptor agonists vs. DPP-4 inhibitors and basal insulin in type 2 diabetes mellitus: A systematic review and meta-analysis.

Marc Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.